Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
SLE group
The First People's Hospital of Lianyungang
Lupus Nephritis
1 trial -
SPECT/CT imaging with 99mTc-P137 nuclide probe
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
SSRI
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
SSRI treated group
Samsung Bioepis NL B.V.
Depression
2 trials -
SSRIs
The First People's Hospital of Lianyungang
Major Depressive Disorder
2 trials -
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Depressive Disorder
1 trial -
Salvianolic Acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stroke
1 trial -
Sana Device (Control)
Sana Biotechnology
Fibromyalgia
1 trial -
Sapropterin
BioMarin Pharmaceutical Australia Pty Ltd
Hyperphenylalaninemia
1 trial -
Sarcosine
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Sarcosine Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Parkinson's Disease With Dementia
1 trial -
Saturated fat
United Therapeutics Europe Ltd
Cardiovascular Disease
1 trial -
Screening only
Hospital Authority, Hong Kong
Panic Attacks and Disorders
1 trial -
Seasonal malaria chemoprevention
United Therapeutics Europe Ltd
Malaria
1 trial -
Secukinumab 300 MG; Tofacitinib 11mg
The First People's Hospital of Lianyungang
Hidradenitis Suppurativa
1 trial -
Selective Serotonin Reuptake Inhibitors (SSRIs)
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Semaglutide
GT Biopharma
Obesity (Disorder)
1 trial -
Semaglutide, 0.5 mg/mL
United Therapeutics Europe Ltd
Cognitive Change
1 trial -
Senl_B19 autologous CAR-T (S1904) treatment
The First People's Hospital of Lianyungang
Relapsed Adult ALL
1 trial -
Seromycin (D-cycloserine, DCS)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Addiction
1 trial -
Sertraline plus placebo of JWXYJN
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depressive Disorder
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Aged
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Anesthesia, General
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Liver Transplantation
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources